Barriers and Solutions to Smart Clinical Program Designs
How the Clinical Development Design (CDD) Framework can offer repeatable, reusable clinical designs based on "enabling information."
MythBusting: 6 eConsent Myths we Need to Correct in 2018
Debunking the six most common myths regarding electronic informed consent.
Eli Lilly Joins the Force on Clinical Trial Patient Education
In this interview, Kevin Hudziak will expand on Lilly’s initiatives to change the face of clinical trials through patient engagement and education initiatives.
The Pull and Tug on Orphan Drug Development
Jill Wechsler on the tug of war in accelerating orphan drug development.
The Commedia Dell'Arte of the EMA Relocation
Relocating the European Medicines Agency was always going to be hard-but no-one ever expected it to degenerate into farce.
Patient Input into Leveraging the Healthcare Professional’s Role
The second series of results from the Center for Information and Study on Clinical Research Participation’s (CISCRP) landmark 2017 Perceptions & Insights Study.
The Impetus for Natural History Studies in Rare Disease R&D
The use of natural history (NH) studies early in clinical research can help facilitate development programs for orphan drugs.
All in Our Heads? The Power of Placebo Response
Lisa Henderson discusses randomized clinical trials with active and non-active placebo treatments.
Applied Clinical Trials, April 2018 Issue (PDF)
Click the title above to open the Applied Clinical Trials April 2018 issue in an interactive PDF format.